Description

Top Quality CP 55,940 for Sale In Stock

What is CP 55,940?

CP 55,940 is a synthetic cannabinoid that acts as a full agonist at both cannabinoid CB₁ and CB₂ receptors, and can also upregulate serotonin 5-HT_2A receptors. Buy CP 55-940 Online

Effect of CP 55,940, Buy CP 55-940 Online

Above all CP 55,940 is a synthetic cannabinoid that mimics the effects of naturally occuring tetrahydrocannabinol (THC).

Similarly it acts as a full agonist at cannabinoid receptors type 1 and 2. These GPCRs are potential  targets for a variety of diseases, including epilepsy, cancer, obesity, and so osteoporosis.

Therefore we offer both agonist and  also antagonist radioligands for autoradiographic visualization or performing saturation and so, competition assays to determine receptor expression levels (B_max), dissociation constants (K_d), association and also dissociation rates (k_on and k_off), and also inhibitor constants (K_i) for a variety of receptors.

In order words we develop our radioligands to the highest specific activity possible and as a result provide high purity resulting in low non-specific binding products.

Also each of our ultra-pure radioligands is fully characterized for pharmacological action and so validated in receptor binding assays.

Product Information

So, Cas No.	83002-04-4
So,Purity	≥98%
Formula	C24H40O3
Formula Wt.	376.58
Chemical Name	2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
IUPAC Name	2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
Synonym	CP-55940, CP 55,940, (-)-CP-55940
Solubility	100mM in ethanol 100mM in DMSO
So, Appearance	White powder

 

Similarly, CP 55,940 is a non-selective, synthetic agonist of the cannabinoid receptors.

So, it has shown activity in anti-cancer, anti-nociceptive, anti-hyperalgesic and  so anti-neurodegenerative capacity.

So more recent studies demonstrated the ability of CP 55,940 to decrease cancer-related pain in mouse models.

As a result in mice models with induced hyperalgesia, CP 55,940 administration improved the response of mice in a paw-withdrawal assay.

However in CB1 knockout mice, similarly  CP 55,940 decreased the amount of allodynia pain in a paclitaxel-induced neuropathy.

So, CB₁ receptors are primarily located at central and peripheral nerve terminals.

However CB₂ receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and also cell migration.

In conclusion recent reports have suggested that CB₂ receptors may also be express in the CNS

Nevertheless  this product is not suitable for human consumption or Veterinary use.